PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Fred Hutchinson Cancer Research Center, Vaccines and Infectious Diseases Division, Seattle, WA, USA.\', \'Division of Infectious Disease, Department of Pediatrics, Emory Vaccine Center, Yerkes National Primate Research Center, Emory University School of Medicine, Atlanta, GA, USA.\', \'Department of Global Health, University of Washington, Seattle, WA, USA.\', \'Fred Hutchinson Cancer Research Center, Vaccines and Infectious Diseases Division, Seattle, WA, USA. mpancera@fredhutch.org.\', \'Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institute of Health, Bethesda, MD, USA. mpancera@fredhutch.org.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41467-020-19231-9
?:hasPublicationType
?:journal
  • Nature communications
is ?:pmid of
?:pmid
?:pmid
  • 33110068
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.582
?:rankingScore_hIndex
  • 198
is ?:relation_isRelatedTo_publication of
?:title
  • Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all